The objective of this proposal is to investigate the role of an adhesion molecule, CD44, in human colorectal carcinoma metastasis with the goal of improving detection and treatment of patients with this disease. CD44 is a cell surface adhesion molecule that is normally present in several isoforms and is postulated to facilitate normal lymphocyte recirculation by modulating adhesion of lymphocytes to specialized lymph node endothelium. Experimental data support the notion that tumor cells may gain access to lymph nodes by mimicking lymphocytes in their cell surface expression of a specific CD44 isoform, CD44R1. By developing CD44R1 specific antibodies as well as experimentally manipulating CD44R1 expression in colorectal carcinoma cells, we propose to improve our understanding of colorectal carcinoma metastasis in a manner that 1) increases the clinically useful prognostic information obtained from primary colorectal tumors; 2) provides a model for treatment of colorectal carcinoma metastases; and 3) enhances detection of asymptomatic patients with colorectal carcinoma. First, we will measure CD44R1 transcript and protein expression in clinical specimens representing primary colorectal tumors, metastases, and normal colonic mucosa. CD44R1-specific antisera will be developed using recombinant fusion proteins for the protein measurements. CD44R1 expression levels will be correlated with clinical and pathological parameters of metastatic disease. Second, we will examine the function of CD44R1 in vivo in a human colorectal carcinoma cell line, KM12, implanted into nude mice. We will examine the ability to modulate metastatic potential by experimentally manipulating CD44R1 expression in these cells. We will also assess the ability to block metastasis in this model using CD44-immunoglobulin fusion proteins. Third, we will use the specific CD44 antisera to develop an assay to detect colorectal carcinoma cells shed into the stool by virtue of their abnormal CD44R1 expression. We will use these results to develop a screening test to detect patients with colorectal carcinomas by examining stool smears. The proposed project will shed new light on mechanisms of human colorectal carcinoma metastasis in a manner that will aid in the detection and therapy of patients with this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29CA064454-01
Application #
2106935
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1994-08-01
Project End
1999-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Kulu, Y; Kawasaki, H; Donahue, J M et al. (2013) Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis. Cancer Gene Ther 20:133-40
Kasuya, Hideki; Pawlik, Timothy M; Mullen, John T et al. (2004) Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen. Cancer Res 64:2561-7
Nakamura, Hideo; Kasuya, Hideki; Mullen, John T et al. (2002) Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5. J Clin Invest 109:871-82
Pawlik, Timothy M; Nakamura, Hideo; Mullen, John T et al. (2002) Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene. Cancer 95:1171-81
Pawlik, T M; Nakamura, H; Yoon, S S et al. (2000) Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res 60:2790-5
Choi, S H; Takahashi, K; Eto, H et al. (2000) CD44s expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 85:523-6
Yoon, S S; Nakamura, H; Carroll, N M et al. (2000) An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J 14:301-11
Eto, H; Yoon, S S; Bode, B P et al. (2000) Mapping and regulation of the tumor-associated epitope recognized by monoclonal antibody RS-11. J Biol Chem 275:27075-83
Yoon, S S; Carroll, N M; Chiocca, E A et al. (1999) Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy. J Gastrointest Surg 3:34-48
Yoon, S S; Eto, H; Lin, C M et al. (1999) Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 59:6251-6

Showing the most recent 10 out of 21 publications